Tryptyr (Acoltremon)

Acoltremon is an eye drop used to treat dry eye. You put a drop in each eye. It is thought to work by switching on the cooling nerves in the eye, which signals the eye to make more of its own tears.

Brand names:Tryptyr
Medication

What people taking Tryptyr (Acoltremon) report

Every report comes from a Lived member, sent anonymously.

Have you tried Tryptyr (Acoltremon) for Dry Eye?

NameHow it went

About Tryptyr (Acoltremon)

What It's For

Acoltremon, sold as Tryptyr, is a prescription eye drop for the signs and symptoms of dry eye disease. Dry eye disease is a common condition in which the eyes do not make enough tears to stay wet, or the tears do not work as they should. It can cause a scratchy feeling as if something is in the eye, stinging or burning, redness, sensitivity to light and blurry vision. Tryptyr was approved in the United States in 2025 and works differently from older dry eye treatments: rather than adding moisture from outside or calming inflammation, it prompts the eye to make more of its own tears. It is approved for adults; its safety and effectiveness have not been established in children.

How It Works

The front of the eye is packed with nerve endings that sense temperature. One type, a cold-sensing receptor called TRPM8 (transient receptor potential melastatin 8), responds to cooling, and when it is activated the nerves that supply the eye signal the tear glands to produce more of the steady, background tears that keep the eye's surface coated. Acoltremon activates these cold-sensing receptors, which increases this baseline tear production. The drug label notes that this mechanism comes mainly from animal studies and that exactly how it improves dry eye disease is not fully understood.

Dosage & Administration

Tryptyr is a 0.003% eye drop that comes in single-dose vials. The usual instruction is one drop in each eye twice a day, about 12 hours apart. Wash your hands first. One vial is enough for both eyes; use it right after opening and throw it away afterward, even if some liquid remains. Keep unopened vials in their foil pouch until you need them. Do not let the tip of the vial touch your eye or any other surface, which can injure the eye or contaminate the drop. Take contact lenses out before using it and wait 15 minutes before putting them back in. If you use other eye drops, space them at least five minutes apart. If you miss a dose, simply take the next one at the usual time.

Side Effects

The most common side effect is discomfort when the drop goes in, described as pain, burning or stinging. In clinical trials about half of the people using Tryptyr noticed it, but fewer than 1 in 100 stopped treatment because of it. Knowing to expect this sensation can make the first few doses less unsettling. Because very little of the drug reaches the bloodstream, effects elsewhere in the body were not a notable problem in the trials. Eye pain that persists well after the drop goes in, increasing redness or a change in vision is not the expected brief sting and is worth raising with the eye care clinician.

Interactions & Warnings

The label lists no conditions in which Tryptyr must be avoided and does not list any drug interactions. It can be used alongside other eye drops, including artificial tears, as long as they are given at least five minutes apart. Let your eye care clinician know about every eye product you use. After use in the eye, the amount of acoltremon reaching the bloodstream is very low. There are no adequate studies in pregnancy and no information on whether it passes into breast milk, so anyone pregnant, planning pregnancy or breastfeeding should weigh the need for treatment with their clinician.

What to Expect

In the two main trials, tear production was measured with a Schirmer test, in which a thin paper strip is placed at the edge of the lower eyelid and the length of strip moistened by tears is measured in millimeters. After two weeks, about 43% to 53% of people using Tryptyr had an increase of at least 10 millimeters, compared with about 8% to 14% of people using inactive drops, and the effect held through three months. The label reports these tear measurements rather than how much symptoms improved, and people did not use artificial tears during the studies, so how much difference it makes for an individual will vary. Dry eye disease is usually a long-term condition, and Tryptyr is meant to be used regularly rather than only when eyes feel dry. Follow-up with an eye care clinician helps judge whether it is helping enough to continue, or whether to add or switch to another treatment.

Questions to Ask Your Doctor

  1. 1.What is causing my dry eye, and is a drug that boosts tear production a good fit for that cause?
  2. 2.How does Tryptyr compare with artificial tears or other prescription dry eye drops for my situation?
  3. 3.How long should I use it before we decide whether it is working, and how will we judge that?
  4. 4.Can I keep using my current eye drops or contact lenses, and how should I time them around Tryptyr?
  5. 5.Is Tryptyr covered by my insurance, and what are the alternatives if it is not?

Last reviewed • Oct 2026

Educational content, not medical advice.